The plasma oxylipin signature provides a deep phenotyping of metabolic syndrome complementary to the clinical criteria

HIGHLIGHTS

• who: Cu00e9line Dalle and colleagues from the Universitu00e9 Auvergne, Clermont-Ferrand, France Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany have published the article: The Plasma Oxylipin Signature Provides a Deep Phenotyping of Metabolic Syndrome Complementary to the Clinical Criteria, in the Journal: (JOURNAL)
• what: The outcome of the studies was the MetS as defined by Alberti et al .
• how: The results are consistent with a previous clinical trial showing lower levels of 9- and 13-HODE in very-low-density lipoproteins (VLDL) and in LDL from MetS subjects (n . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.